Biogen Lacked Intent To Defraud, Shareholder Suit Judge Says
A Massachusetts federal judge on Tuesday dropped a shareholder suit accusing the biopharmaceutical company Biogen Inc. of misrepresenting the effect that the death of a clinical study patient had on its...To view the full article, register now.
Already a subscriber? Click here to view full article